66 related articles for article (PubMed ID: 18854288)
1. Increased serum tumor markers (CA125 and CA15.3) in primary plasma cell leukemia: a case report and review of the literature.
de Larrea CF; Cibeira MT; Vallansot R; Colomo L; Bladé J
Clin Lymphoma Myeloma; 2008 Oct; 8(5):312-4. PubMed ID: 18854288
[TBL] [Abstract][Full Text] [Related]
2. Microchip fluorescence-enhanced immunoaasay for simultaneous quantification of multiple tumor markers.
Shi M; Zhao S; Huang Y; Liu YM; Ye F
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep; 879(26):2840-4. PubMed ID: 21873123
[TBL] [Abstract][Full Text] [Related]
3. Serum tumour markers in patients with chronic kidney disease.
Xiaofang Y; Yue Z; Xialian X; Zhibin Y
Scand J Clin Lab Invest; 2007; 67(6):661-7. PubMed ID: 17852811
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
Li CS; Cheng BC; Ge W; Gao JF
Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612
[TBL] [Abstract][Full Text] [Related]
5. Increased serum CA125 levels in plasma cell dyscrasias.
Iwasaki T; Hamano T; Aizawa K; Kobayashi K; Kakishita E
Acta Haematol; 1997; 98(2):104-8. PubMed ID: 9286307
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing serum concentration of CA125 and CA15-3 in Iranian healthy postmenopausal women.
Dehaghani AS; Ghiam AF; Hosseini M; Mansouri S; Ghaderi A
Pathol Oncol Res; 2007; 13(4):360-4. PubMed ID: 18158573
[TBL] [Abstract][Full Text] [Related]
7. Microarray Glycoprofiling of CA125 improves differential diagnosis of ovarian cancer.
Chen K; Gentry-Maharaj A; Burnell M; Steentoft C; Marcos-Silva L; Mandel U; Jacobs I; Dawnay A; Menon U; Blixt O
J Proteome Res; 2013 Mar; 12(3):1408-18. PubMed ID: 23360124
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic value of multiple tumor marker detection for mature and immature teratoma of the ovary].
Chen C; Li JD; Huang H; Feng YL; Wang LH; Chen L
Ai Zheng; 2008 Jan; 27(1):92-5. PubMed ID: 18184473
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Baratti D; Kusamura S; Martinetti A; Seregni E; Laterza B; Oliva DG; Deraco M
Ann Surg Oncol; 2007 Aug; 14(8):2300-8. PubMed ID: 17510772
[TBL] [Abstract][Full Text] [Related]
10. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
[TBL] [Abstract][Full Text] [Related]
11. Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases.
Nicolini A; Tartarelli G; Carpi A; Metelli MR; Ferrari P; Anselmi L; Conte M; Berti P; Miccoli P
BMC Cancer; 2006 Nov; 6():269. PubMed ID: 17116247
[TBL] [Abstract][Full Text] [Related]
12. Potential markers that complement expression of CA125 in epithelial ovarian cancer.
Rosen DG; Wang L; Atkinson JN; Yu Y; Lu KH; Diamandis EP; Hellstrom I; Mok SC; Liu J; Bast RC
Gynecol Oncol; 2005 Nov; 99(2):267-77. PubMed ID: 16061277
[TBL] [Abstract][Full Text] [Related]
13. Relationship of serum levels of tumor markers with tissue expression of gene products in ovarian carcinoma.
Sorak M; Arsenijević S; Lukić G; Arsenijević N; Ristić P; Pavlović S; Popović S; Baskić D
J BUON; 2007; 12(1):99-104. PubMed ID: 17436409
[TBL] [Abstract][Full Text] [Related]
14. The use of mucin-specific monoclonal antibodies and lectins in the detection of tumor-associated serum markers in gynecological cancer.
Devine PL; McGuckin MA; Ramm LE; Harada H; Ward BG
Cancer Biochem Biophys; 1993 Sep; 13(4):221-38. PubMed ID: 8521372
[TBL] [Abstract][Full Text] [Related]
15. Multiple myeloma with serous membrane involvement and increased CA-125 and CA 15-3.
Gunaldi M; Helvaci A; Demirel Yildirim N; Aydin D; Kara N
J BUON; 2011; 16(4):778. PubMed ID: 22331737
[No Abstract] [Full Text] [Related]
16. Ultrasensitive molecularly imprinted fluorescence sensor for simultaneous determination of CA125 and CA15-3 in human serum and OVCAR-3 and MCF-7 cells lines using Cd and Ni nanoclusters as new emitters.
Bahari D; Babamiri B; Salimi A
Anal Bioanal Chem; 2021 Jun; 413(15):4049-4061. PubMed ID: 34057557
[TBL] [Abstract][Full Text] [Related]
17. Impact of serum tumor marker determination on the management of women with borderline ovarian tumors: multivariate analysis of a French multicentre study.
Poncelet C; Fauvet R; Yazbeck C; Coutant C; Darai E
Eur J Surg Oncol; 2010 Nov; 36(11):1066-72. PubMed ID: 20817462
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy with bortezomib, cyclophosphamide and dexamethasone may be effective for plasma cell leukemia.
Kim SJ; Kim J; Cho Y; Seo BK; Kim BS
Jpn J Clin Oncol; 2007 May; 37(5):382-4. PubMed ID: 17538191
[TBL] [Abstract][Full Text] [Related]
19. [Serum CA125 level associated with disease activity in a patient with follicular lymphoma].
Kuroda H; Kida M; Watanabe H; Shirao S; Konda K
Rinsho Ketsueki; 2005 Apr; 46(4):281-3. PubMed ID: 16444962
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of serum Her2/neu, BCL2, CA15-3 and CEA in breast cancer patients: a short follow-up.
Samy N; Ragab HM; El Maksoud NA; Shaalan M
Cancer Biomark; 2010; 6(2):63-72. PubMed ID: 20571232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]